Jarol, Alkhalid P.
HRN: 18-60-22 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/07/2025
CEFUROXIME 750MG (VIAL)
03/07/2025
03/14/2025
IV
600MG
Q8
Pcap C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes